Bile bilirubin pigment analysis in disorders of bilirubin metabolism in early infancy
Open Access
- 1 July 2001
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 85 (1) , 38-42
- https://doi.org/10.1136/adc.85.1.38
Abstract
BACKGROUND Early and accurate diagnosis of Crigler–Najjar syndrome, which causes prolonged unconjugated hyperbilirubinaemia in infancy, is important, as orthotopic liver transplantation is the definitive treatment. AIM To determine whether bilirubin pigment analysis of bile in infants with prolonged unconjugated hyperbilirubinaemia provides useful diagnostic information in the first 3 months of life. METHODS Retrospective review of patients with prolonged unconjugated hyperbilirubinaemia referred to the liver unit, Birmingham Children's Hospital, for the diagnosis of Crigler–Najjar syndrome. Bile bilirubin pigment composition was determined by high performance liquid chromatography. Initial diagnoses were made based on the result of bile bilirubin pigment composition. Final diagnoses were made after reviewing the clinical course, response to phenobarbitone, repeat bile bilirubin pigment composition analysis, and genetic studies. RESULTS Between 1992 and 1999, nine infants aged less than 3 months of age with prolonged hyperbilirubinaemia underwent bile bilirubin pigment analyses. Based on these, two children were diagnosed with Crigler–Najjar syndrome (CNS) type 1, six with CNS type 2, and one with Gilbert's syndrome. Five children whose initial diagnosis was CNS type 2 had resolution of jaundice and normalisation of serum bilirubin after discontinuing phenobarbitone, and these cases were thought to be normal or to have Gilbert's syndrome. One of the initial cases of CNS type 1 responded to phenobarbitone with an 80% reduction in serum bilirubin consistent with CNS type 2. In all, the diagnoses of six cases needed to be reviewed. CONCLUSIONS Early bile pigment analysis, performed during the first 3 months of life, often shows high levels of unconjugated bilirubin or bilirubin monoconjugates, leading to the incorrect diagnosis of both type 1 and type 2 Crigler–Najjar syndrome.Keywords
This publication has 19 references indexed in Scilit:
- Diagnosis and management of Crigler-Najjar syndromeEuropean Journal of Pediatrics, 1999
- Current Therapy for Crigler–Najjar Syndrome Type 1: Report of A World RegistryHepatology, 1996
- ORTHOTOPIC LIVER TRANSPLANTATION FOR CRIGLER-NAJJAR TYPE I DISEASE IN SIX CHILDRENTransplantation, 1995
- Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase.Journal of Clinical Investigation, 1994
- Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro.Journal of Clinical Investigation, 1994
- High-performance liquid chromatographic analysis of bile pigments as their native tetrapyrroles and as their dipyrrolic azosulfanilate derivativesJournal of Chromatography B: Biomedical Sciences and Applications, 1990
- Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liverBiochemical Journal, 1979
- Effect of Phenobarbitone on Plasma [14C]Bilirubin Clearance in Patients with Unconjugated HyperbilirubinaemiaClinical Science, 1974
- Effect of sodium phenobarbital on bilirubin metabolism in an infant with congenital, nonhemolytic, unconjugated hyperbilirubinemia, and kernicterusJournal of Clinical Investigation, 1969
- REDUCTION OF SERUM-UNCONJUGATED-BILIRUBIN WITH PHENOBARBITONE IN ADULT CONGENITAL NON-HÆMOLYTIC UNCONJUGATED HYPERBILIRUBINÆMIAThe Lancet, 1968